Corpus Intelligence IC Memo — ST VINCENT GENERAL HOSPITAL 2026-04-26 15:54 UTC
IC Memo — ST VINCENT GENERAL HOSPITAL
Investment Committee Memorandum | CO | 8 beds | Grade C | EBITDA uplift $970K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST VINCENT GENERAL HOSPITAL

CCN 061319 | nan, CO | 8 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST VINCENT GENERAL HOSPITAL is a 8-bed under-performing / distressed in nan, CO with $13.1M in net patient revenue and a -94.9% operating margin. The hospital serves a payer mix of 47.8% Medicare, 15.7% Medicaid, and 36.5% commercial.

Thesis: Turnaround. Our ML models identify $970K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -94.9% to -87.5% (+738bps).

Net Revenue HCRIS$13.1M
Current EBITDA COMPUTED$-12.5M
Operating Margin COMPUTED-94.9%
Occupancy HCRIS20.7%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS47.8%
Distress Probability ML59.6%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
11
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -94.9% places it below the state median. Among 11 size-comparable peers (4-16 beds), the median margin is -14.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-16), prioritizing same-state peers. 11 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST VINCENT GENERAL HOSPITAL (Target)CO8$13.1M-94.9%
NATIONAL JEWISH HEALTHCO13$150.4M-50.0%
ANIMAS SURGICAL HOSPITALCO12$47.4M13.7%
PIONEERS MEDICAL CENTERCO16$43.9M-5.9%
WRAY COMMUNITY DISTRICT HOSPITCO16$34.0M4.0%
PAGOSA SPRINGS MEDICAL CENTERCO11$33.8M-32.9%
PIKES PEAK REGIONAL HOSPITALCO13$26.3M-9.3%
MELISSA MEMORIAL HOSPITALCO15$23.9M-2.4%
YUMA DISTRICT HOSPITALCO15$22.6M-14.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $970K (738bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$276K+210bp18mo
Cost to Collect4.5%2.5%$263K+200bp12mo
Denial Rate Reduction12.0%6.5%$261K+199bp12mo
A/R Days Reduction5200.0%3800.0%$160K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$276K
Cost to Collect
$263K
Denial Rate Reduction
$261K
A/R Days Reduction
$160K
Clean Claim Rate
$10K
Total EBITDA Uplift$970K
Current EBITDA$-12.5M
+ RCM Uplift+$970K
Pro Forma EBITDA$-11.5M
Current Margin-94.9%
Pro Forma Margin-87.5%
WC Released (1x)$504K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-19.2M$-72.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-19.2M$-86.1M0.00x-100.0%
Bull Case9.0x11.0x$-17.3M$-89.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-17.3M$-102.4M0.00x-100.0%
Bear Case11.0x10.0x$-21.1M$-71.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-21.1M$-85.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 20.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 11 hospitals with 4-16 beds
  • Same-state prioritization (n=13)
  • Comp margins: P25=-29.0% / P50=-14.0% / P75=-4.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.